Post by AGC Biologics

The demand for high-quality bispecific antibody manufacturing is on the rise, and at AGC we’re investing in the latest technologies to help our clients advance this promising therapeutic modality. Learn about the strategies we use for improving gene integration, increasing titers, and enhancing the stability of bispecifics in our blog, linked in the comments below.⬇️ #Bispecifics #Antibodies #CellLineDevelopment #Transposase #Biopharma #yourfriendlyCDMOexpert